TABLE 1.
Patient characteristics
| Patient | Age, years | Sex | Tanner stage |
Disease classification
|
Prestudy characteristics
|
||
|---|---|---|---|---|---|---|---|
| Localization | Method of Dx | Duration of Sx | Prestudy therapy | ||||
| 1 | 13 | M | 3 | Ileum | Endo + Bx | 6 m | Steroids |
| 2 | 15 | F | 3 | Ileum | Endo + Bx | 3 m | None |
| 3 | 15 | M | 4 | Ileum+colon | Endo + Bx | 10 m | Flagyl* |
| 4 | 11 | M | 2 | Ileum + colon | Endo + Bx | 6 m | 5-ASA |
| 5 | 17 | F | 3 | Ileum | Endo + Bx | 18 m | 5-ASA, Steroids |
| 6 | 14 | F | 3 | Ileum + colon | Endo + Bx | 1 m | None |
| 7 | 18 | F | 4 | Ileum + colon | Endo + Bx | 12 m | 5-ASA, steroids |
*
Searle, USA. ASA Aminosalicylic acid; Bx Biopsy; Dx Diagnosis; Endo Endoscopy; F Female; M Male; m Months; Sx Symptoms